The Association of Obesity Indices and Cardiovascular Risk in Korean Type 2 Diabetes

Jae Hyuk Lee

Article

Korean J Obes 2013; 22(4): 212-214

Published online December 31, 2013

The Association of Obesity Indices and Cardiovascular Risk in Korean Type 2 Diabetes

Jae Hyuk Lee^*

Author Affiliations

Department of Endocrinology, MyongJi Hospital

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

References

Go to

References

Catenacci VA, Hill JO, Wyatt HR. The obesity epidemic. Clin Chest Med 2009;30:415-44.
Wajchenberg BL. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev 2000;21:697-738.
Arner P. Regional differences in protein production by human adipose tissue. Biochem Soc Trans 2001;29:72-5.
Bergholm R, Tiikkainen M, Vehkavaara S, Tamminen M, Teramo K, Rissanen A, et al. Lowering of LDL cholesterol rather than moderate weight loss improves endothelium-dependent vasodilatation in obese women with previous gestational diabetes. Diabetes Care 2003;26:1667-72.
Sasaki S, Higashi Y, Nakagawa K, Kimura M, Noma K, Sasaki S, et al. A low-calorie diet improves endothelium-dependent vasodilation in obese patients with essential hypertension. Am J Hypertens 2002;15:302-9.
L?pez-Jim?nez F, Cort?s-Bergoderi M. Update: systemic diseases and the cardiovascular system (i): obesity and the heart. Rev Esp Cardiol 2011;64:140-9.
The Global Burden of Metabolic Risk Factors for Chronic Diseases Collaboration (BMI Mediated Effects). Metabolic mediators of the effects of body-mass index, overweight, obesity on coronary heart disease and stroke: a pooled analysis of 97 prospective cohorts with 1·8 million participants. Lancet 2013 [Epub ahead of print].
Romero-Corral A, Somers VK, Sierra-Johnson J, Korenfeld Y, Boarin S, Korinek J, et al. Normal weight obesity: a risk factor for cardiometabolic dysregulation and cardiovascular mortality. Eur Heart J 2010;31:737-46.
Ashwell M, Hsieh SD. Six reasons why the waist-to-height ratio is a rapid and effective global indicator for health risks of obesity and how its use could simplify the international public health message on obesity. Int J Food Sci Nutr 2005;56:303-7.
Savva SC, Lamnisos D, Kafatos AG. Predicting cardiometabolic risk: waist-to-height ratio or BMI. A meta-analysis. Diabetes Metab Syndr Obes 2013:6:403 -19.
van Dijk SB, Takken T, Prinsen EC, Wittink H. Different anthropometric adiposity measures and their association with cardiovascular disease risk factors: a meta-analysis. Neth Heart J 2012;20:208-18.
Despr?s JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature 2006;444:881-7.
Chopra H, Kaur S, Sambi RS. Potbelly-the most powerful predictor of metabolic syndrome and premature morbidity and mortality. Indian Heart J 2007;59:56-63.
Browning LM, Hsieh SD, Ashwell M. A systematic review of waist-to-height ratio as a screening tool for the prediction of cardiovascular disease and diabetes:0.5 could be a suitable global boundary value. Nutr Res Rev 2010;23:247-69.
Ashwell M, Gunn P, Gibson S. Waist-to-height ratio is a better screening tool than waist circumference and BMI for adult cardiometabolic risk factors:systematic review and meta-analysis. Obes Rev 2012;13:275-86.
Prasad DS, Kabir Z, Dash AK, Das BC. Abdominal obesity, an independent cardiovascular risk factor in Indian subcontinent: A clinico epidemiological evidence summary. J Cardiovasc Dis Res 2011;2:199-205.
Yoo SY, Kim MY, Kim SH, Kim SH, Ko SJ, Beom JW, et al. Relationship between obesity indices and cardiovascular risk score in Korean type 2 diabetes patients. Korean J Obes 2013;22:148-54.